Ivy Brain Tumor Center

The Ivy Brain Tumor Center is here to serve as a resource to the world's brain tumor community. Patients enrolled in our studies are not required to transfer their care to our Center, as our philosophy is to partner with, not replace, their treatment team. While assessing a patient's suitability for our clinical trials program, our dedicated team also provides support to the physicians managing these cases and works in partnership to create a patient-centered path forward.

There are many benefits associated with this choice, the most important ones being: -You are matched to an available experimental therapy based on a combination of different genetic biomarkers and criteria. -You will have results within 10 days of surgery. If the Phase 0 study drugs do not have the desired effect, you won't lose time seeking out other treatment options. Your involvement helps researchers uncover better ways to treat, prevent, diagnose, and understand brain tumors. You may or may not directly benefit from participating in the study; however, the information gained from this study will help other people in the future.

As each study is unique in enrollment criteria, we encourage you to submit your information through our secure Trial Screening portal. Someone from our team will reach out to you within two business days to follow up with you on enrollment requirements.

As part of a clinical trial at the Ivy Brain Tumor Center, the study drugs will be provided free of charge, however, the patient and/or their health plan/insurance company will be responsible for some or all of the costs of treating the tumor in the study, including any standard medical care such as surgical resection. We encourage all patients to ask their study doctor to discuss the costs that will or will not be covered by the study, including who will pay the costs of treating possible side effects.

Clinical trials are a very important part of clinical research. Ivy Phase 0/2 clinical trials, in particular, combine the early development of new drugs with treatments for cancer and other diseases. They bridge the gap between initial drug testing and patient studies, with the goal of providing a better understanding of how a drug works in a shorter amount of time and for less cost. Ivy Phase 0/2 clinical trials match brain tumor patients to first-in-class drug combinations, confirm drug effects within days of exposure, and only treat patients when therapies are active in their own tumor.

For brain tumor patients facing the fight of their lives, no stone should be left unturned. Our team treats more brain tumor patients than any hospital in the nation and our portfolio of early-phase clinical trials serves as resource for the world's brain tumor community -- we are ready to take on every individualized challenge with a new approach. Seeking medical treatment can also place a huge burden on patients and their families. At the Ivy Brain Tumor Center, Trial Screening Requests are provided at no cost and, for patients we determine to be eligible for clinical trials, we cover all costs associated with study participation outside of the standard of care.